<DOC>
	<DOCNO>NCT01665378</DOCNO>
	<brief_summary>Low birth weight anemia remain intractable problem many develop country despite considerable effort address . Intervening prenatal iron-folate ( IFA ) supplement may best approach give substantial demand iron maternal fetal tissue . Therefore , urgent need evaluate additional contribution prepregnancy intervention . We propose double blind randomize controlled trial rural Vietnam evaluate efficacy weekly pre- pregnancy IFA Multiple Micronutrient ( MM ) supplement birth outcome maternal infant iron status compare provide prenatal IFA supplement . This project collaborative effort Emory University , USA Thainguyen University Medicine Pharmacy , Vietnam . Eligible willing woman reproductive age ( WRA ) assign randomly one follow 3 group pre-pregnancy weekly supplementation : 1 ) FA ( control ) 2 ) IFA 3 ) MM . All woman receive daily IFA pregnant . We recruit ~ 5000 WRA obtain sample least 1650 mother-infant pair , , 90 % power , allow u detect difference ~ 60 g birth weight two group . Data obstetric history , socio-demographic status , iron status , anthropometry dietary intake obtain baseline . Key outcome measure 1 ) offspring 's size gestational age birth 2 ) offspring 's iron status birth 3 month age 3 ) maternal iron status begin pregnancy , 1 3 month post-partum . Intention treat approach use compare various intervention group . This study timely respond WHO Global Expert Consultation ( 2007 ) identify need evaluate long term benefit weekly IFA MM supplementation WRA . The finding provide necessary evidence policy maker recommend weekly MM IFA supplement WRA improve birth outcome . The central hypothesis pre-pregnancy weekly IFA MM supplementation follow prenatal IFA MM supplementation respectively , improve birth outcomes well maternal infant iron status compare current practice provide prenatal IFA supplement . This hypothesis test conduct randomize double-blinded placebo-controlled trial Vietnam .</brief_summary>
	<brief_title>Impact Pre-pregnancy Micronutrient Supplementation Maternal Child Outcomes</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Thiamine</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Micronutrients</mesh_term>
	<mesh_term>Trace Elements</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>1835 year old Currently marry Intends live study area next 24 month Plans child next year Agrees participate informed consent Currently pregnant Delivered previous six month Regularly consume IFA MM supplement past 2 month Severe anemia ( Hb &lt; 7 g/L ) History high risk pregnancy include abruptio placenta , placenta previa , gestational diabetes , pregnancy induce hypertension , coagulation disorder , thrombocytopenia chronic vascular , renal systemic disease drug use Chronic hematological disease , hereditary defect red cell hemoglobin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>prepregnancy</keyword>
	<keyword>micronutrient</keyword>
	<keyword>supplementation</keyword>
	<keyword>maternal</keyword>
	<keyword>child</keyword>
	<keyword>health</keyword>
</DOC>